Author:
Verma Vaneeta,Mann Amandeep,Costain Willard,Pontoriero Giuseppe,Castellano Jessica M.,Skoblenick Kevin,Gupta Suresh K.,Pristupa Zdenek,Niznik Hyman B.,Johnson Rodney L.,Nair Venugopalan D.,Mishra Ram K.
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference38 articles.
1. Barbeau A, Roy M, Gonce M, and Labreoque L (1978) Newer therapeutic approaches in Parkinson's Disease, in Advances in Neurology (Poirier LJ, Sourkes TL, and Bedard PJ eds), pp 433–437, Raven Press, New York.
2. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites
3. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
4. Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献